![[TXT]](/icons/text.gif) 121b.1002-The_value_of_cIMT_for_predicting_CV_risk_Simon,_ATVB_s.pdf | 266.80Kb | February 13 2010 |
| 131.1002-Smoking_cessation_Chandler,_Chest_s.pdf | 833.68Kb | February 13 2010 |
| 140.1002-Combined_Warfarin-Aspirin_therapy,_what_is_the_evidence_for_..._Donadini,_JTT_s.pdf | 149.29Kb | February 13 2010 |
| 141.1002-Aspirin_for_Iary_prevention_of_CV_events_in_diabetes._MA_Zhang,_Diab_Res_Clin_Pract_s.pdf | 897.60Kb | February 13 2010 |
| 255T.1001ep-Filter_protected_vs_Unprotected_CAS,_RCT_Macdonald,_CVD_s.pdf | 165.71Kb | February 13 2010 |
| 261.1002-Stenting_of_Sympt_and_Asympt_VA_stenosis,_to_treat_or_not_to_treat_Parkhutik,_Eur_J_Neurol_s.pdf | 134.57Kb | February 13 2010 |
| 311.0912ep-High_prevalence_of_PAD_in_patients_with_acute_ischemic_stroke_Topakian,_CVD_s.pdf | 145.14Kb | February 13 2010 |
| 335.1002-Trends_in_LL_amputations_in_people_with_and_without_diabetes._England_1996-2005_Vamos,_Diab_Res_CP_s.pdf | 466.99Kb | February 13 2010 |
| 371.1002-Site_specificity_of_aneurysmal_disease_Norman,_Circulation_s.pdf | 459.47Kb | February 13 2010 |
| 411.1003-Capillary_dimension_measured_by_computer-based_digitalized_image_..._in_SS_Kim,_Clin_Rheumatol_s.pdf | 248.95Kb | February 13 2010 |
| 421.1003-Mycophenolate_mofetil_in_Takayasu'arteritis_Goel,_Clin_Rheumatol_s.pdf | 73.54Kb | February 13 2010 |
| 422.1002-Pulmonary_and_Vascular_Manifestaion_of_Behcet_Desease.pdf | 1.06Mb | February 13 2010 |
| 600.1002-Development_of_national_performance_measures_on_the_prevention_and_treatment_of_VTE_Bratzler,_JTT_s.pdf | 245.70Kb | February 13 2010 |
| 615.1003-Is_opium_addiction_a_RF_for_DVT,_case-control_study_Masoomi,_Blood_Coag_Fib_s.pdf | 273.39Kb | February 13 2010 |
| 616.1002-Postmenopausal_hormone_therapy_and_risk_of_VTE._E3N_Cohort_Canonico,_ATVB_s.pdf | 284.31Kb | February 13 2010 |
| 620.1001-Reducing_the_risk_of_VTE_in_patients_admitted_to_hospital_NICE_(full_text)_s.pdf | 3.06Mb | February 13 2010 |
| 620.1001-Reducing_the_risk_of_VTE_in_patients_admitted_to_hospital_Summary_of_NICE_guidance,_bmj_s.pdf | 96.19Kb | February 13 2010 |
| 620.1001-VTE,_reducing_the_risk_NICE_(Quick_reference_guide)_s.pdf | 367.01Kb | February 13 2010 |
| 623.1002-VTE_during_pregnancy,_postpartum_or_during_contraceptive_use_Blanco-Molina,_Blood_Coag_Fib_s.pdf | 77.54Kb | February 13 2010 |
| 633.1002-Risk_of_DVT_following_a_single_negative_whole-leg_CUS._SR-MA_Johnson,_jama_s.pdf | 364.28Kb | February 13 2010 |
| 633.1002-Success_of_a_safe_and_simple_algorythm_to_reduce_use_of_CTPA_in_emergency_department_Stein,_ajr_s.pdf | 583.06Kb | February 13 2010 |
| 653.1002-Frequency,_demographics_and_risk_of_Kc-associated_DVT_among_patients_seen_at_outpatient_clinics_Paneesha,_Blood_Coag_Fib_s.pdf | 461.17Kb | February 13 2010 |
| 70.1002-What_you_should_know_about_the_2008_ACCP_guidelines_on_Antithrombotic_and_Thrombolytic_therapy_Kaatz,_JTT_s.pdf | 161.11Kb | February 13 2010 |
| 718.1002-The_role_of_perforators_in_CVI_O'Donnell,_Phlebology_s.pdf | 597.84Kb | February 13 2010 |
| 73.1002-New_oral_AC,_a_practical_guide_for_clinicians_Wittkowsky,_JTT_s.pdf | 165.37Kb | February 13 2010 |
| 73.1002-Update_on_heparin,_what_do_we_need_to_know_Weitz,_JTT_s.pdf | 199.60Kb | February 13 2010 |
| 74.1002-Warfarin_anticoagulation_reversal._Management_of_asymptomatic_and_bleeding_patient_Makris,_JTT_s.pdf | 185.28Kb | February 13 2010 |
| 75.1002-To_bridge_or_not_to_bridge,_that_is_the_question._The_argument_FOR_bridging_...._Spyropoulos,_JTT_s.pdf | 142.68Kb | February 13 2010 |
| 764.1002-Sclerotherapy,_a_study_comparing_polidocanol_in_foam_and_liquid_form_Uncu,_Phlebology_s.pdf | 77.71Kb | February 13 2010 |
| 765.1002-Endovenous_Tt_for_VV,_over-taking_or_over-rated_Shepherd,_Phlebology_s.pdf | 133.25Kb | February 13 2010 |
![[DIR]](/icons/back.gif){kind=icon}
Parent Directory